Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124260694 | 12426069 | 4 | F | 20160523 | 20160726 | 20160601 | 20160801 | EXP | IT-JNJFOC-20160525240 | PHARMACYCLICS | 83.57 | YR | E | F | Y | 0.00000 | 20160801 | CN | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124260694 | 12426069 | 1 | SS | IMBRUVICA | IBRUTINIB | 1 | Oral | Y | N | 23155 | 0 | 280 | MG | CAPSULE | |||||
| 124260694 | 12426069 | 2 | PS | IMBRUVICA | IBRUTINIB | 1 | Oral | Y | N | 23155 | 205552 | 420 | MG | CAPSULE | |||||
| 124260694 | 12426069 | 3 | SS | PRADAXA | DABIGATRAN ETEXILATE MESYLATE | 1 | Oral | Y | 0 | 300 | MG | CAPSULE, HARD | |||||||
| 124260694 | 12426069 | 4 | SS | PRADAXA | DABIGATRAN ETEXILATE MESYLATE | 1 | Oral | Y | 0 | 220 | MG | CAPSULE, HARD | |||||||
| 124260694 | 12426069 | 5 | C | LASIX | FUROSEMIDE | 1 | Oral | 0 | 25 | MG | TABLETS | ||||||||
| 124260694 | 12426069 | 6 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | 0 | 150 | MG | TABLETS | BID | |||||||
| 124260694 | 12426069 | 7 | C | CARDICOR | BISOPROLOL | 1 | Oral | 0 | 3.75 | MG | TABLETS | ||||||||
| 124260694 | 12426069 | 8 | C | CARDURA | DOXAZOSIN MESYLATE | 1 | Oral | 0 | 2 | MG | |||||||||
| 124260694 | 12426069 | 9 | C | TRIATEC | RAMIPRIL | 1 | Oral | 0 | 2.5 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124260694 | 12426069 | 1 | Chronic lymphocytic leukaemia |
| 124260694 | 12426069 | 2 | Chronic lymphocytic leukaemia |
| 124260694 | 12426069 | 3 | Atrial fibrillation |
| 124260694 | 12426069 | 4 | Atrial fibrillation |
| 124260694 | 12426069 | 5 | Hypertension |
| 124260694 | 12426069 | 6 | Prophylaxis |
| 124260694 | 12426069 | 7 | Hypertension |
| 124260694 | 12426069 | 8 | Hypertension |
| 124260694 | 12426069 | 9 | Cardiac failure |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124260694 | 12426069 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124260694 | 12426069 | Asthenia | |
| 124260694 | 12426069 | Confusional state | |
| 124260694 | 12426069 | Pyrexia | |
| 124260694 | 12426069 | Subdural haematoma |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124260694 | 12426069 | 1 | 20160517 | 20160523 | 0 | |
| 124260694 | 12426069 | 2 | 20150227 | 201507 | 0 | |
| 124260694 | 12426069 | 3 | 20160506 | 20160522 | 0 | |
| 124260694 | 12426069 | 4 | 20150922 | 0 | ||
| 124260694 | 12426069 | 5 | 20151012 | 0 | ||
| 124260694 | 12426069 | 6 | 20150317 | 20160523 | 0 | |
| 124260694 | 12426069 | 7 | 20151012 | 20160523 | 0 | |
| 124260694 | 12426069 | 9 | 20150225 | 0 |